Chipiron Funding News- France-based Chipiron raises €14.9M

The funding round was led by Blast, with support from the EIC Fund, iXcore, and public programs like France2030, the EIC Accelerator, and Bpifrance.

Anthony Bourbon, Founder and CEO of Blast.Club, says, “Chipiron is exactly the kind of biotech we want to boost at Blast. They’re making possible what traditional medicine still struggles to do: detect life-threatening diseases early. A major public health issue, breakthrough technology, and a strong team. Proud to support them through Blast.Club.”

Hervé Arditty, President of iXcore, adds, “iXcore chose to invest in Chipiron for three reasons: the team is outstanding, the science and technology behind this MRI are perfectly mastered, and the company is clearly offering a game-changing product.”

The EIC Fund says its investment in Chipiron supports its goal of funding major tech innovations in important industries like healthcare.

Since starting in 2020, the EIC Fund has supported nearly 40 medical technology companies, working with top venture capital firms in Europe and beyond.

Chipiron will use the new funding to keep developing its small, advanced MRI scanner and get it ready for use in hospitals.

The company plans to finish its research, build clinical test models using ultra-low-field MRI, and start patient trials in 2026.

In the next three to five years, Chipiron plans to launch its first clinical use, get FDA and CE approvals, and install 100 MRI systems.

Evan Kervella, CEO and co-founder, says, “This fundraising marks a major turning point for Chipiron, as it validates both our technological approach and the clinical impact we aim to achieve. Thanks to the trust of our investors, we now have the means to complete our R&D phase and begin clinical investigations in hospitals as early as next year.”

“Our goal has remained the same since day one: to transform MRI accessibility and  fundamentally change medical care worldwide.”

Dimitri Labat, CSO and co-founder, adds, “We will unlock Chipiron’s most important value inflection point early next year by demonstrating the clinical relevance of our technology.”

“Thanks to this round led by Blast, we will be able to install our first device in a hospital to acquire MRI images of patients in a real-world environment. These images will form the basis for the product that will profoundly transform medical imaging practice on a global scale.”

About Chipiron

Chipiron is working to change healthcare by creating MRI machines that are small, portable, and affordable. Their goal is to make getting an MRI as easy and accessible as getting a blood test.